The hemolytic and complement-activating properties of pneumolysin do not contribute individually to virulence in a pneumococcal bacteremia model

Microbial Pathogenesis

Volumn 23, Issue 4, 1997, Pages 201-209

  Benton, Kimberly A ^a   Paton, James C ^b   Briles, David E ^a  

^a University of Alabama at Birmingham   (United States)

^b WOMEN S AND CHILDREN S HOSPITAL   (Australia)

Author keywords

Bacteremia; Complement; Hemolysis; Pneumolysin; Streptococcus pneumoniae

Indexed keywords

COMPLEMENT; PNEUMOLYSIN;

ANIMAL MODEL; ARTICLE; BACTEREMIA; BACTERIAL VIRULENCE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; GROWTH; HEMOLYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE; SURVIVAL TIME;

EID: 0030848504     PISSN: 08824010     EISSN: None     Source Type: Journal    
DOI: 10.1006/mpat.1997.0150     Document Type: Article

References (22)

1. Berry A.M., Yother J., Briles D.E., Hansman D., Paton J.C. Reduced virulence of a defined pneumolysin-negative mutant ofStreptococcus pneumoniae. Infect Immun. 57:1989;2037-2042.
2. Berry A.M., Paton J.C., Hansman D. Effect of insertional inactivation of the genes encoding pneumolysin and autolysin on the virulence ofStreptococcus pneumoniae. Microb Pathog. 12:1992;87-93.
3. Benton K.A., Everson M.P., Briles D.E. A pneumolysin-negative mutant ofStreptococcus pneumoniae. Infect Immun. 63:1995;448-455.
4. Rubins J.B., Charboneau D., Paton J.C., Mitchell T.J., Andrew P.W., Janoff E.N. Dual function of pneumolysin in the early pathogenesis of murine pneumococcal pneumonia. J Clin Invest. 95:1995;142-150.
5. Canvin J.R., Marvin A.P., Sivakumaran M. The role of pneumolysin and autolysin in the pathology of pneumonia and septicemia in mice infected with a type 2 pneumococcus. J Infect Dis. 172:1995;119-123.
6. Alouf, JE, Geoffroy, C, 1991, In: Alouf JE, Freer JH, Eds.Sourcebook of Bacterial Toxins, 147, 86.
7. Bhakdi S., Tranum-Jensen J. Damage to mammalian cells by proteins that form transmembrane pores. Rev Physiol Biochem Pharmacol. 107:1987;147-223.
8. Owen R.H.G., Boulnois G.J., Andrew P.W., Mitchell T.J. A role in cell-binding for the C-terminus of pneumolysin, thiol-activated toxin ofStreptococcus pneumoniae. FEMS Microbiol Lett. 121:1994;217-222.
9. Paton J.C., Andrew P.W., Boulnois G.J., Mitchell T.J. Molecular analysis of the pathogenicity ofStreptococcus pneumoniae. Annu Rev Microbiol. 47:1993;89-115.
10. Paton J.C. The contribution of pneumolysin to the pathogenicity ofStreptococcus pneumoniae. Trends Microbiol. 4:1996;103-106.
11. Paton J.C., Rowan-Kelly B., Ferrante A. Activation of human complement by the pneumococcal toxin pneumolysin. Infect Immun. 43:1984;1085-1087.
12. Mitchell T.J., Andrew P.W., Saunders F.K., Smith A.N., Boulnois G.J. Complement activation and antibody binding by pneumolysin via a region of the toxin homologous to a human acute-phase protein. Mol Microbiol. 5:1991;1883-1888.
13. Berry A.M., Alexander J.E., Mitchell T.J., Andrew P.W., Hansman D., Paton J.C. Effect of defined point mutations in the pneumolysin gene on the virulence ofStreptococcus pneumoniae. Infect Immun. 63:1995;1969-1974.
14. Rubins J.B., Charboneau D., Fasching C. Distinct roles for pneumolysin's cytotoxic and complement activities in the pathogenesis of pneumococcal pneumonia. Am J Respir Crit Care Med. 153:1996;1339-1346.
15. Alexander, JE, Berry, AM, Paton, JC, Rubins, JB, Andrew, PW, Mitchell, TJ, The course of pneumococcal pneumonia is altered by amino acid changes affecting the activity of pneumolysin. (submitted.
16. Ong G.L., Mattes M.J. Mouse strains with typical mam-malian levels of complement activity. J Immunol Meth. 125:1989;147-158.
17. Ong G.L., Baker A.E.M., Mattes M.J. Analysis of high complement levels inMus hortulanus. J Immunol Meth. 154:1992;37-45.
18. Rosenberg L.T., Tachibana D.K. On mouse complement: genetic variants. J Immunol. 103:1969;1143-1148.
19. Amsbaugh D.F., Hansen C.T., Prescott B., Stashak P.W., Barthold D.R., Baker P.J. Genetic control of the antibody response to type III pneumococcal polysaccharide in mice. I. Evidence that an X-linked gene plays a decisive role in determining responsiveness. J Exp Med. 136:1972;931-949.
20. Mond J.J., Lieberman J.R., Inman J.K., Moiser D.E., Paul W.E. Inability of mice with defect in B-lymphocyte maturation to respond to phosphocholine on immunogenic carriers. J Exp Med. 146:1977;1138-1142.
21. Briles D.E., Nahm M., Schroer K. Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3Streptococcus pneumoniae. J Exp Med. 153:1981;694-705.
22. Sultzer B.M. Genetic control of leukocyte responses to endotoxin. Nature. 219:1968;1253-1254.